Inventor · San Diego, CA, US

Todd Macklin

16Patents
3h-index
9Co-inventors
45Inventor score

Filing activity: Jul 16, 2013 → Nov 30, 2018

Most-cited inventions

PatentTitleAreaCited byStatus
US9012447B2 5-HT3 receptor antagonists Chemistry; Metallurgy 7 Active
US9346829B2 5-HT3 receptor antagonists Chemistry; Metallurgy 4 Active
US9487526B2 Quinoxaline derivatives as GPR6 modulators Chemistry; Metallurgy 3 Active
US9670229B2 5-HT3 receptor antagonists Chemistry; Metallurgy 3 Active
US9303045B2 5-HT3 receptor antagonists Chemistry; Metallurgy 2 Active
US9770452B2 Quinoxaline derivatives as GPR6 modulators Chemistry; Metallurgy 2 Active
US9708313B2 Substituted pyrido[3,4-b]pyrazines as GPR6 modulators Human Necessities 1 Active
US9181249B2 Substituted pyrido[3,4-b]pyrazines as GPR6 modulators Human Necessities 1 Active
US10179783B2 Tetrahydropyridopyrazines as modulators of GPR6 Human Necessities 1 Active
US10077266B2 Substituted pyrido[3,4-b]pyrazines as GPR6 modulators Human Necessities 1 Active
US10597392B2 Tetrahydropyridopyrazines as modulators of GPR6 Human Necessities 0 Active
US10406157B2 Tetrahydropyridopyrazine modulators of GPR6 Chemistry; Metallurgy 0 Active
US10125145B2 5-HT3 receptor antagonists Chemistry; Metallurgy 0 Active
US10407443B2 5-HT3 receptor antagonists Chemistry; Metallurgy 0 Active
US9695195B2 5-HT3 receptor antagonists Chemistry; Metallurgy 0 Active
US10738046B2 Substituted pyrido[3,4-b]pyrazines as GPR6 modulators Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.